Therapeutic Goods Act 1989
Approval under section 42DF for use of a restricted representation by Swisse Vitamins Pty Ltd
I, Dr Jane Cook, Office Head, Office of Product Review, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing, on receipt of an application by Swisse Vitamins Pty Ltd, have approved under section 42DF (1) of the Therapeutic Goods Act 1989 (the Act) the restricted representation described in paragraph (a) below for use on the label and in advertisements directed to consumers, for the products identified in paragraph (b):
- "Diabetes" - only in the context of the statement "Swisse proudly donate a percentage of the profits to support the research of Baker IDI Heart and Diabetes Institute" accompanied by the Baker IDI Heart & Diabetes Institute logo.
- Swisse Ultiboost Odourless Wild Fish Oil (ARTG 190245); Swisse Ultiboost Wild Fish Oil (190244); Swisse Ultiboost Wild Krill Oil + Fish Oil Concentrate Heart (ARTG 194383).
Dated this 4 day of April 2012
Dr Jane Cook
Delegate of the Secretary to the Department of Health and Ageing; and
Office Head
Office of Product Review